European Medicines Agency

FDA

FDA panel sees risk in long-used osteoporosis drug

WASHINGTON (AP) — A panel of federal health experts says a long-established bone strengthening drug should no longer be used by women because there is little evidence it works and it may actually increase the risk of cancer.

03/05/2013

British medical journal slams Roche on Tamiflu

LONDON (AP) — A leading British medical journal is asking the drug maker Roche to release all its data on Tamiflu, claiming there is no evidence the drug can actually stop the flu. The drug […]

11/13/2012

Follow

Get every new post delivered to your Inbox.

Join 28,184 other followers